Ads

You May Also Like

Stemline Therapeutics Announces Positive Data Presentations on SL-701 and SL-801 at ASCO

NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

MRG-106 Phase 1 trial expanded to include additional oncology indications, enrollment commencedMRG-201 expected to ...